Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=КОМБРЕТАСТАТИН<.>)
Общее количество найденных документов : 60
Показаны документы с 1 по 20
 1-20    21-40   41-60  
1.
A novel combretastatin A-4 derivatvie, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors // Jap. J. Cancer Res., 1999. Vol. 90, N 9.-С.1016-1025

2.
A novel combretastatin A-4 derivatvie, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors // Jap. J. Cancer Res., 1999. Vol. 90, N 9.-С.1016-1025

3.
A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours // Brit. J. Clin. Pharmacol., 2011. Vol. 71, N 6.-С.860-870

4.
Antitumor effects due to irreversible stoppage of tumor tissue blood flow: Evaluation of a novel combretastatin A-4 derivative, AC7700 // Jap. J. Cancer Res., 1999. Vol. 90, N 9.-С.1026-1038

5.
Antitumor effects due to irreversible stoppage of tumor tissue blood flow: Evaluation of a novel combretastatin A-4 derivative, AC7700 // Jap. J. Cancer Res., 1999. Vol. 90, N 9.-С.1026-1038

6.
Chaplin D.J. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate // Anticancer Res., 1999. Vol. 19, N 1a.-С.189-195

7.
Chaplin D.J. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate // Anticancer Res., 1999. Vol. 19, N 1a.-С.189-195

8.
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues // Cancer Res., 1999. Vol. 59, N 7.-С.1626-1634

9.
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues // Cancer Res., 1999. Vol. 59, N 7.-С.1626-1634

10.
D'Amato Estrogenic compounds as anti-mitotic agents

11.
D'Amato Estrogenic compounds as anti-mitotic agents

12.
D'Amato Estrogenic compounds as anti-mitotic agents

13.
D'Amato Estrogenic compounds as anti-mitotic agents

14.
D'Amato Estrogenic compounds as anti-mitotic agents

15.
In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes // Drug Metab. and Dispos., 2007. Vol. 35, N 12.-С.2252-2261

16.
In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation // Anticancer Res., 2006. Vol. 26, N 1A.-С.307-310

17.
In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation // Anticancer Res., 2006. Vol. 26, N 1A.-С.307-310

18.
In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation // Anticancer Res., 2006. Vol. 26, N 1A.-С.307-310

19.
Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4{1} // Cancer Res., 1998. Vol. 58, N 20.-С.4510-4514

20.
Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4{1} // Cancer Res., 1998. Vol. 58, N 20.-С.4510-4514

 1-20    21-40   41-60  
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)